(Adds analyst comment, 2015 forecast, sales details). By Bill Berkrot. Jan 27 (Reuters) - Amgen Inc on Tuesday reported higher-than-expected fourth-quarter profit, driven by strong sales of its blockbuster rheumatoid arthritis drug Enbrel and a tax credit.
Amgen profit tops expectations on Enbrel sales, tax credit
Amgen beats 4Q net income and revenue expectations
Greenfield Daily Reporter